Cytotoxic T cell mechanisms of beta cell destruction in non-obese diabetic mice

Thomas W H Kay1, Nadine L Dudek, Kate Graham

  • 1St. Vincent's Institute of Medical Research, 41 Victoria Parade, Fitzroy 3065, Victoria, Australia.

Novartis Foundation Symposium
|February 11, 2009
PubMed

Insights

CD8+ T cells destroy beta cells via perforin and Fas pathways. Strategies targeting these, like reducing antigen presentation or combining interventions, show promise for preventing type 1 diabetes.

Area of Science:

  • Immunology
  • Endocrinology
  • Molecular Biology

Background:

  • CD8+ T cells are key drivers of beta cell destruction in NOD mice.
  • Perforin, granzymes, and Fas ligand are implicated molecular mediators.
  • Cytokines may influence the immune response rather than directly target beta cells.

Purpose of the Study:

  • To investigate the molecular mechanisms of beta cell destruction in NOD mice.
  • To evaluate the therapeutic potential of inhibiting specific molecular mediators.
  • To explore combined intervention strategies for enhanced protection.

Main Methods:

  • In vitro studies of beta cell-specific CD8+ T cell cytotoxicity.
  • In vivo studies using NOD mouse models with genetic modifications (e.g., perforin deficiency, cytokine deficiency).
  • Overexpression of suppressors of cytokine signaling 1 (SOCS1) to reduce antigen presentation.

Main Results:

  • Beta cell-specific CD8+ T cells utilize both perforin and Fas pathways.
  • Reducing MHC class I expression via SOCS1 overexpression protects beta cells in vivo.
  • Perforin deficiency reduces diabetes in NOD mice, but compensatory mechanisms exist in NOD8.3 mice.
  • Cytokine deficiency (IL-1, TNF, Fas) shows protective effects, primarily by modulating the immune response.

Conclusions:

  • Multiple molecular mediators contribute to beta cell destruction.
  • Targeting antigen presentation and cytotoxic pathways offers therapeutic potential.
  • Combined interventions, such as SOCS1 overexpression and IL-1 deficiency, may provide significant protection against diabetes.

Related Concept Videos

Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...